Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adequate immunotoxicity testing in drug development.

Danuta J Herzyk1, Elizabeth R Gore

  • 1Department of Safety Assessment, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406, USA. danuta.j.herzyk@gsk.com

Toxicology Letters
|April 20, 2004
PubMed
Summary

Evaluating drug-induced immune system changes is crucial. This study discusses methods to identify immunotoxicants, focusing on T-cell responses to ensure pharmaceutical safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model.

Journal of immunotoxicology·2020
Same author

<i>In vitro</i> and <i>in vivo</i> induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor.

Haematologica·2020
Same author

A hit deconstruction approach for the discovery of fetal hemoglobin inducers.

Bioorganic & medicinal chemistry letters·2018
Same author

Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies.

The AAPS journal·2018
Same author

An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors.

Birth defects research. Part B, Developmental and reproductive toxicology·2016
Same author

Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cells.

Journal of biomolecular screening·2013

Area of Science:

  • Immunology
  • Toxicology
  • Pharmacology

Background:

  • Drug and chemical exposures can unintendedly modulate immune responses, leading to immunostimulation or immunosuppression.
  • True immunotoxicity is defined by adverse effects or defects in immune response following such exposures.
  • Regulatory bodies require standardized methods to assess potential pharmaceutical immunotoxicity.

Purpose of the Study:

  • To address the need for reliable and standardized methods for evaluating potential immunotoxicity of pharmaceuticals.
  • To discuss the establishment of criteria for classifying drugs as immunotoxicants.
  • To present examples of a modified approach for assessing T-cell-dependent antibody responses in immunotoxicity evaluation.

Main Methods:

  • Utilized a modified approach to measure T-cell-dependent antibody responses.
  • Employed the rat Keyhole Limpet Hemocyanin (KLH) model for immune response assessment.
  • Interpreted results within the framework of immunotoxicity evaluation.

Main Results:

  • Demonstrated the application of a modified T-cell-dependent antibody response assay.
  • Provided insights into interpreting results for immunotoxicity classification.
  • Highlighted the utility of the rat KLH model in this context.

Conclusions:

  • Standardized methods are essential for regulatory evaluation of pharmaceutical immunotoxicity.
  • The discussed approach offers a reliable way to assess T-cell-mediated immune responses.
  • Further development of criteria and methods will aid in identifying immunotoxicants.

Related Experiment Videos